Supernus hits Zydus with repeat suit over migraine drug
20-09-2021
Takeda v Zydus: FTC intervenes in sham lawsuit claims
11-06-2018
stockdevil /iStockphoto.com
Speciality pharmaceutical company Supernus has settled patent disputes over Trokendi XR (topiramate), a treatment for partial seizures, with US-based Zydus Pharmaceuticals and Actavis Laboratories.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Actavis, Zydus, Supernus, seizure, Trokendi XR, ANDA, FDA, patent, patent infringement,
